Videos:
20 August, 2021 – Australian MP Craig Kelly Interviews Dr. Brian Tyson
26 March, 2021 – DR. ZELENKO DISCUSSES COVID-19 OUTPATIENT MANAGEMENT
AMERICA’S FRONTLINE DOCTORS PRESS CONFERENCE AT WASHINGTON, DC
Hydroxychloroquine could save up to 100,000 lives if used for COVID-19: Yale epidemiology professor
Research/Articles
3 January, 2023 – The War on Hydroxychloroquine (HCQ)
Today, Dr McCullough recommended this article from Dr. Eleftherios Gkioulekas
Presentation: Statistical evidence from case series data in support of early outpatient COVID-19 treatment protocols (substack.com)
Note that, even now, the C19 mRNA injections are “Emergency Use Authorized” and must be withdrawn if an alternative exists.
Both HCQ and Ivermectin ARE such alternatives. By not acting the FDA is guilty of wilful misconduct and a breach of the charter that governs its actions.
10 October, 2023 – Another One Bites the Dust The HCQ conspiracy theory is well and truly buried.
Those who did not receive HCQ had a 57% greater chance of dying, all other things being equal!
https://metatron.substack.com/p/another-one-bites-the-dust?publication_id=579085&post_id=137827074&isFreemail=true&r=tx5ig My research and reporting of HCQ started in summer of 2020, well before the disastrous mass gene therapy experiment:
https://www.linkedin.com/posts/joelsmalley_covid19-hcq-hydroxychloroquine-activity-6697742999901749248-9-Uq/ A summary of research and (medical) expert opinion on hydroxychloroquine (HCQ) and Ivermectin treatment for COVID19.
https://lnkd.in/dss52YE
https://lnkd.in/dyMggkD
https://lnkd.in/dDGYjqy
https://lnkd.in/dWiE7EJ
https://lnkd.in/dahdiwg
https://lnkd.in/d-6Dwzk
https://lnkd.in/dgkW-wt
https://lnkd.in/d7EsHTz
https://lnkd.in/d5j3rsi
https://lnkd.in/dypjpWE
https://lnkd.in/d-vUqBp
https://lnkd.in/duF-_5z
https://lnkd.in/dDvSTCR
#covid19 #hcq #hydroxychloroquine #redpill #ivermectin
10 October, 2023 – We told them the hydroxychloroquine science was overwhelming & here more evidence accumulates:
Meeus et al. finding that Treatment of COVID-19 using combination of hydroxychloroquine plus azithromycin was safe and was associated with a statistically significant mortality benefit in the treatment of COVID-19 infection in hospitalized patients; no harms; Risch, McCullough, Ladapo, Tenenbaum, Zelenko https://www.sciencedirect.com/science/article/pii/S2052297523000914?via%3Dihub
8 May, 2023 – Variation in Demographic Characteristics, Socioeconomic Status, Clinical Presentation and Selected Treatments in Mortality Among Patients with a Diagnosis of COVID-19 in the United States
A just published peer-reviewed study from the USA has found that Covid patients treated with REMDESIVIR (Run/death/is/near) were ~ 5 times more likely to die than those treated with either IVERMECTIN or HYDROXYCHLOROQUINE.
However, it’s possible that it’s even worse than that, as the raw numbers are surprisingly not adjusted for the decline in mortality rate over time, nor the differences across age groups.
Nevertheless the raw data indicates that banning the use of Ivermectin & HCQ while pushing Remdesivir was an act of gross criminal incompetence that costs thousands of lives.
A screenshot taken Dec 24, 2020, of thelancet.com, shows the retracted study that prompted some countries to ban the use of hydroxychloroquine to treat COVID-19. (Screenshot/TheLancet.com/Epoch Times)
26 May, 2023 – Over 300 COVID-19 Papers Withdrawn for Not Meeting Standards of Scientific Soundness
18 May, 2020 – Combination of zinc, HCQ & azithromycin helps in recovery from COVID-1
5 June, 2020 – The Lancet Retracts Hydroxychloroquine Study
“A first-year statistics major could tell you about major flaws in the design of the analysis,” one expert said.
5 June, 2020 – The Lancet retracts large study on Hydroxychloroquine
“The reviewers were unable to conduct “an independent and private peer review” and withdrew from the process, The Lancet said.”
“The large number of patients raised important questions among outside experts.”
“The amount of patients that were included in a given country or given continent was almost more or a very high proportion of the total number reported in that geographic area, as if they were including more cases than possible,” said Dr. Daniel Culver, a pulmonary and critical care expert at the Cleveland Clinic who was not involved with the research.”
March 30, 2020 – CORONAVIRUS: New York doctor successfully treats patients with drug cocktail
“Given the urgency of the situation, I developed the following treatment protocol in the pre-hospital setting and have seen only positive results:
Any patient with shortness of breath regardless of age is treated.
Young, healthy and low-risk patients even with symptoms are not treated (unless their circumstances change and they fall into category 1 or 2).
Hydroxychloroquine 200mg twice a day for 5 days; Azithromycin 500mg once a day for 5 days; Zinc sulfate 220mg once a day for 5 days.
– Dr. Zev Zelenko, Board Certified Family Practitioner.
December, 2020 – COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study – peer reviewed
“Only diagnosed COVID-19 patients who met the defined risk stratification requirements of group A, B or C received a prescription for the following triple therapy for 5 consecutive days in addition to standard supportive care: zinc sulfate (220 mg capsule once daily, containing 50 mg elemental zinc); HCQ (200 mg twice daily); and azithromycin (500 mg once daily). No loading dose was used. Patients who did not meet the risk stratification requirements received standard of care to treat common upper respiratory tract infections. Patients were not treated with HCQ if they had known contraindications, including QT prolongation, retinopathy or glucose-6-phosphate dehydrogenase deficiency.”
COVID-19 Outpatients – Early Risk-Stratified Treatment with Zinc Plus Low Dose Hydroxychloroquine and Azithromycin: A Retrospective Case Series Study pre-print
Observational Study on 255 Mechanically Ventilated Covid Patients at the Beginning of the USA Pandemic
Hydroxychloroquine Protocol Continues Getting Censored.pdf
COVID Hydroxychloroquine Scandal
Some of the doctors who are successfully curing COVID patients with Hydroxychloroquine that the Globalists are trying to silence. Why?
Is the 100% Cure Rate of Hydroxychloroquine a Threat to Fast-Tracking the COVID Vaccines?
California Medical Doctor Cures Over 1700 Patients with COVID Using Hydroxychloroquine
California Medical Doctor Cures Over 1700 Patients with COVID Using Hydroxychloroquine.pdf
Dallas Physician Heals COVID Patients Successfully with non-FDA Approved Hydroxychloroquine After Hospitals Sent them Home with no Treatment
Dallas Physician Heals COVID Patients Successfully with non-FDA Approved Hydroxychloroquine After Hospitals Sent them Home with no Treatment.pdf
AAPS Sues the FDA to End Its Arbitrary Restrictions on Hydroxychloroquine
AAPS Sues the FDA to End Its Arbitrary Restrictions on Hydroxychloroquine.pdf
Survey Shows Overwhelming Majority of Doctors Would Prescribe Hydroxychloroquine to a Family Member With Wuhan Coronavirus
Survey Shows Overwhelming Majority of Doctors Would Prescribe Hydroxychloroquine to a Family Member With Wuhan Coronavirus.pdf
Medicines for the Prevention of Malaria While Traveling Hydroxychloroquine (Plaquenil™)
Medicines for the Prevention of Malaria While Traveling – Hydroxychloroquine.pdf
A Report on Successful Treatment of Coronavirus
A Report on Successful Treatment of Coronavirus.pdf
Cuba: Early hydroxychloroquine potent against COVID-19
Cuba_ Early hydroxychloroquine potent against COVID-19.pdf
NEW Study: Hydroxychloroquine Treatment of COVID had a 79% Lower Mortality Rate than Countries that Banned it
COVID-19 Treatment – Analysis of 206 global studies showing high efficacy for early treatment
COVID-19 Treatment – Analysis of 206 global studies showing high efficacy for early treatment.pdf
NEW Study: Hydroxychloroquine Treatment of COVID had a 79% Lower Mortality Rate than Countries that Banned it
Australian Politician Calls for Criminal Trials of Health Bureaucrats who Banned Hydroxychloroquine as COVID Cure.pdf
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
“All patients in Marseille center were proposed oral hydroxychloroquine sulfate 200 mg, three times per day during ten days.”
“At day 6 post-inclusion, 100% of patients treated with hydroxychloroquine and azithromycin combination were virologicaly cured comparing with 57.1% in patients treated with hydroxychloroquine only, and 12.5% in the control group (p<0.001).”
Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Results of an Open-Label Non-Randomized Clinical Trial: Response to criticisms.
Hydroxychloroquine and Azithromycin as a Treatment of COVID-19 – Results of an Open-Label Non-Randomized Clinical Trial – Response to Criticisms.pdf
Dr. Meryl Nass Discovers Hydroxychloroquine Experiments Were Designed to Kill COVID Patients – How Many Were Murdered?
Dr. Meryl Nass Discovers Hydroxychloroquine Experiments Were Designed to Kill COVID Patients – How Many Were Murdered?.pdf
Medical Scandal of the Decade Erupts as Lancet and NEJM Both Retract Studies Finding Hydroxychloroquine Deadly and Ineffective
Association of American Physicians and Surgeons Sues FDA for “Irrational” Interference of Access to Life-Saving Hydroxychloroquine
Fauci knew about HCQ in 2005 — nobody needed to die
Fauci knew about HCQ in 2005 — nobody needed to die.pdf
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread.
Hydroxychloroquine and azithromycin as a treatment of COVID-19.
Largest Statistically Significant Study by 6,200 Multi-Country Physicians on COVID-19 Uncovers Treatment Patterns and Puts Pandemic in Context
COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin..
COVID-19 Outpatients – Early Risk-Stratified Treatment with Zinc Plus Low Dose Hydroxychloroquine and Azithromycin.pdf
Is Quercitin an alternative ‘zinc ionophore’ adjuvant where hydroxychloroquine is unavailable for early treatment of COVID-19?
Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study
Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19.pdf
Infection: A Prospective, Randomized, Controlled, and Open-Label Study
“Quercetin in a delivery-food grade system with sunflower phospholipids (Quercetin Phytosome®, QP) increases its oral absorption up to 20-fold.”
“In the present prospective, randomized, controlled, and open-label study, a daily dose of 1000 mg of QP was investigated for 30 days in 152 COVID-19 outpatients to disclose its adjuvant effect in treating the early symptoms and in preventing the severe outcomes of the disease.”
“..the use as adjuvant therapy of a daily dose of 1000 mg/day of formulated quercetin (2 daily doses of 500 mg each), corresponding to 400 mg of quercetin delivered by sunflower lecithin (a food-grade delivery system used to improve the well-known poor oral bioavailability of quercetin), statistically improved all the clinical outcomes considered (need and length of hospitalization, need of non-invasive oxygen therapy, progression to intensive care units and death)..”
https://www.thorne.com/products/dp/quercetin-phytosome
https://au.iherb.com/pr/thorne-research-quercetin-phytosome-60-capsules/58566?gclsrc=ds
https://rnlabs.com.au/products/rn-labs/research-nutrition-products/quercesorb/
